InvestorsHub Logo
Followers 1
Posts 298
Boards Moderated 0
Alias Born 11/16/2017

Re: SAMNOTSAMUEL post# 32565

Thursday, 02/08/2018 1:40:25 PM

Thursday, February 08, 2018 1:40:25 PM

Post# of 50155
Not mystery. They are no longer note holders and are now long for the ride up. Delcath technology is worth more now than ever. As other cancer fighting methods advance such as gene therapy it's relevance and value is only underscored. Those methods require the exact same kind of organ isolation technology that delcath just so happens to hold the patens on. Not to mention it's already proven value as a lifesaving technology used with current chemotherapeutic applications. With that bad debt out of the way, positive saftey analysis and FDA approval On the horizon you are going to see new money pour into this company soon. With FDA under pressure from POTUS you will see a lot of study's that have been unnesisarily slowed by overregulation be greenlighted and approved ahead of scedual. Delcath will be one of those. IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News